MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
12.62
-0.36
-2.75%
Pre Market: 13.22 +0.6 +4.72% 07:37 05/12 EDT
OPEN
12.97
PREV CLOSE
12.98
HIGH
13.10
LOW
12.49
VOLUME
45
TURNOVER
0
52 WEEK HIGH
21.34
52 WEEK LOW
8.69
MARKET CAP
891.54M
P/E (TTM)
56.20
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHAR last week (0504-0508)?
Weekly Report · 1d ago
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026
TipRanks · 3d ago
DWS Investment discloses 38.4 million voting rights in Pharming Group
PUBT · 3d ago
Pharming Group (PHAR) Gets a Buy from Canaccord Genuity
TipRanks · 3d ago
Pharming price target lowered to $40 from $41 at Oppenheimer
TipRanks · 4d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
Analysts’ Top Healthcare Picks: Argenx Se (ARGX), Pharming Group (PHAR)
TipRanks · 5d ago
Pharming GAAP EPS of $0.00 in-line, revenue of $72.4M misses by $19.67M
Seeking Alpha · 5d ago
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV - ADR stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.